Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CL.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBF.8.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAUNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.25.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XADNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XABNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FT.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XALNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBWNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.1.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GY.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBF.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.10.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FF.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.213NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.56 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.39.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.91.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.14 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.359NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.66NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.485NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.73NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.112.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.8 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.122.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.5.6 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.440NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.23.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.104 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.198NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAFNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.17.1 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used